Sansure Biotech (SHSE:688289) EV-to-Revenue : 6.17 (As of May. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sansure Biotech's enterprise value is ¥7,424 Mil. Sansure Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,203 Mil. Therefore, Sansure Biotech's EV-to-Revenue for today is 6.17.

The historical rank and industry rank for Sansure Biotech's EV-to-Revenue or its related term are showing as below:

SHSE:688289' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.86 Med: 3.4 Max: 17.79
Current: 6.18

During the past 7 years, the highest EV-to-Revenue of Sansure Biotech was 17.79. The lowest was 0.86. And the median was 3.40.

SHSE:688289's EV-to-Revenue is ranked worse than
71.69% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs SHSE:688289: 6.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Sansure Biotech's stock price is ¥20.31. Sansure Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.08. Therefore, Sansure Biotech's PS Ratio for today is 9.78.

Sansure Biotech EV-to-Revenue Historical Data

The historical data trend for Sansure Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech EV-to-Revenue Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

8.70

4.20

1.13

6.94

Sansure Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.64	1.21	1.67	6.94	5.87

Competitive Comparison of Sansure Biotech's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Sansure Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sansure Biotech's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sansure Biotech's EV-to-Revenue falls into.

Sansure Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sansure Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	7423.789	/	1202.893
	=	6.17

Sansure Biotech's current Enterprise Value is ¥7,424 Mil.
Sansure Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,203 Mil.

Sansure Biotech (SHSE:688289) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sansure Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	20.31	/	2.076
	=	9.78

Sansure Biotech's share price for today is ¥20.31.
Sansure Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.08.

Sansure Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech (SHSE:688289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines